Zevenbergen Capital Investments’s Portola Pharmaceuticals, Inc. PTLA Stock Holding History

Zevenbergen Capital Investments’s Portfolio PTLA Stock Details PTLA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-1,137,055	Closed	-$30.3M	–	88
2018 Q3	$30.3M	Sell	1,137,055 -116,570	-9%	-$3.81M	0.96%	36
2018 Q2	$47.3M	Buy	1,253,625 +424,100	+51%	+$16.2M	1.58%	23
2018 Q1	$27.1M	Buy	829,525 +64,050	+8%	+$2.81M	1.04%	33
2017 Q4	$37.3M	Buy	765,475 +187,910	+33%	+$9.5M	1.55%	27
2017 Q3	$31.2M	Buy	577,565 +125,375	+28%	+$7.36M	1.35%	27
2017 Q2	$25.4M	Buy	452,190 +188,320	+71%	+$7.54M	1.1%	33
2017 Q1	$10.3M	Buy	+263,870	New	+$8.4M	0.48%	38

Other funds holding PTLA

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

CCM

Cadian Capital Management New York $821M AUM 14.36% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

JSP

Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Zevenbergen Capital Investments's PTLA Position: Q4 2018 in Review

Zevenbergen Capital Investments sold out of Portola Pharmaceuticals, Inc. (PTLA) in Q4 2018, closing a stake of 1,137,055 shares — an estimated $30.3M sold.

Zevenbergen Capital Investments first reported a position in PTLA in Q1 2017 and held it in 7 quarters. The position peaked at $47.3M in Q2 2018. 181 funds tracked by Wall St. Rank hold PTLA as of Q4 2018.

Zevenbergen Capital Investments reported no remaining Portola Pharmaceuticals, Inc. position as of Q4 2018 after selling out during the quarter.
Zevenbergen Capital Investments sold 1,137,055 Portola Pharmaceuticals, Inc. shares in Q4 2018, an estimated $30.3M.
Zevenbergen Capital Investments first reported a position in Portola Pharmaceuticals, Inc. in Q1 2017 and held it in 7 quarters.
Zevenbergen Capital Investments's Portola Pharmaceuticals, Inc. position peaked at $47.3M in Q2 2018.
181 funds tracked by Wall St. Rank held Portola Pharmaceuticals, Inc. as of Q4 2018.

Based on Zevenbergen Capital Investments's 13F filing for Q4 2018, filed 14 Feb 2019.